Retailers have until Nov. 15 to complete pending applications before that pause takes effect, part of an earlier announcement ...

Hydrofarm maintained its full-year outlook, expecting sales to decline in the "low to high teens" percentage range.

The company's high-profile cannabis-based drug, Epidiolex, accounted for $251.5 million in revenue for the quarter.

MariMed reported that its revenue increased to $40 million in the quarter versus last year’s $38.8 million. This missed the ...

Turning Point Brands (NYSE: TPB) beat analyst estimates and raised its full-year outlook after reporting ...

The cannabis REIT rebounded from the previous quarter’s miss as originations grow and fresh capital continues to expand its ...

The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) reported its financial results for the third quarter that ...

Village Farms International, Inc. (NASDAQ: VFF) reported its financial results for the third quarter ended September 30, 2024 ...

With Florida adult-use out of the picture, the firm seems to be focused on digesting new deals as competitive pressures mount ...

After a string of referendum wins in states such as Ohio, the industry lost in Florida, where it fell short of the 60% ...

CEO Boris Jordan said Curaleaf would continue looking for paths to profitability, including through international expansion.

Unpack the industry with the daily cannabis newsletter for business leaders.